SK280532B6 - Derivát 3-alkoxykarbonyltiadiazinónu, spôsob jeho - Google Patents

Derivát 3-alkoxykarbonyltiadiazinónu, spôsob jeho Download PDF

Info

Publication number
SK280532B6
SK280532B6 SK1652-95A SK165295A SK280532B6 SK 280532 B6 SK280532 B6 SK 280532B6 SK 165295 A SK165295 A SK 165295A SK 280532 B6 SK280532 B6 SK 280532B6
Authority
SK
Slovakia
Prior art keywords
tetrahydro
methyl
quinolyl
dihydro
dimethoxybenzoyl
Prior art date
Application number
SK1652-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK165295A3 (en
Inventor
Rochus Jonas
Ingeborg Lues
Norbert Beier
Klaus-Otto Minck
Original Assignee
Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gesellschaft Mit Beschr�Nkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Publication of SK165295A3 publication Critical patent/SK165295A3/sk
Publication of SK280532B6 publication Critical patent/SK280532B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
SK1652-95A 1995-01-11 1995-12-27 Derivát 3-alkoxykarbonyltiadiazinónu, spôsob jeho SK280532B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19500558A DE19500558A1 (de) 1995-01-11 1995-01-11 3-Alkoxycarbonyl-thiadiazinone

Publications (2)

Publication Number Publication Date
SK165295A3 SK165295A3 (en) 1996-08-07
SK280532B6 true SK280532B6 (sk) 2000-03-13

Family

ID=7751240

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1652-95A SK280532B6 (sk) 1995-01-11 1995-12-27 Derivát 3-alkoxykarbonyltiadiazinónu, spôsob jeho

Country Status (24)

Country Link
US (1) US5705497A (es)
EP (1) EP0721950B1 (es)
JP (1) JP4025377B2 (es)
KR (1) KR100399541B1 (es)
CN (1) CN1055691C (es)
AT (1) ATE165828T1 (es)
AU (1) AU704493B2 (es)
CA (1) CA2166854A1 (es)
CZ (1) CZ292094B6 (es)
DE (2) DE19500558A1 (es)
DK (1) DK0721950T3 (es)
ES (1) ES2120251T3 (es)
GR (1) GR3027566T3 (es)
HK (1) HK1010194A1 (es)
HU (1) HUP9600061A3 (es)
MX (1) MX9600165A (es)
NO (1) NO306300B1 (es)
PL (1) PL183011B1 (es)
RU (1) RU2162087C2 (es)
SI (1) SI0721950T1 (es)
SK (1) SK280532B6 (es)
TW (1) TW407157B (es)
UA (1) UA44249C2 (es)
ZA (1) ZA96177B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
DE19929785A1 (de) 1999-06-29 2001-01-04 Bayer Ag Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung
MX2016016061A (es) * 2014-08-15 2017-03-10 Hoffmann La Roche 2,2,2-trifluoroetil-tiadiazinas.
CN112500353B (zh) * 2020-12-08 2022-11-25 北京晨光同创医药研究院有限公司 一种左西孟旦的前药化合物、制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
DE4041074A1 (de) * 1990-12-21 1992-06-25 Merck Patent Gmbh Thiadiazinonderivate
DE4129062A1 (de) * 1991-09-02 1993-03-04 Merck Patent Gmbh Verfahren zur enantiomerentrennung von 5-hetaryl-1,3,4-thiadiazinonen
DE4134893A1 (de) * 1991-10-23 1993-04-29 Merck Patent Gmbh Thiadiazinone
DE4223537A1 (de) * 1992-07-17 1994-01-20 Merck Patent Gmbh Thiadiazinone
DE4310699A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Thiadiazinone

Also Published As

Publication number Publication date
EP0721950A2 (de) 1996-07-17
DE59600173D1 (de) 1998-06-10
HUP9600061A3 (en) 1998-04-28
SK165295A3 (en) 1996-08-07
NO306300B1 (no) 1999-10-18
CZ292094B6 (cs) 2003-07-16
JPH08253478A (ja) 1996-10-01
DK0721950T3 (da) 1999-02-15
TW407157B (en) 2000-10-01
MX9600165A (es) 1997-01-31
NO960112D0 (no) 1996-01-10
EP0721950A3 (es) 1996-07-24
AU4082696A (en) 1996-07-18
CN1135484A (zh) 1996-11-13
DE19500558A1 (de) 1996-07-18
JP4025377B2 (ja) 2007-12-19
CZ8096A3 (en) 1996-07-17
HUP9600061A2 (en) 1997-10-28
UA44249C2 (uk) 2002-02-15
CN1055691C (zh) 2000-08-23
NO960112L (no) 1996-07-12
CA2166854A1 (en) 1996-07-12
EP0721950B1 (de) 1998-05-06
ZA96177B (en) 1996-07-30
RU2162087C2 (ru) 2001-01-20
PL183011B1 (pl) 2002-05-31
AU704493B2 (en) 1999-04-22
ES2120251T3 (es) 1998-10-16
ATE165828T1 (de) 1998-05-15
KR960029331A (ko) 1996-08-17
HK1010194A1 (en) 1999-06-17
US5705497A (en) 1998-01-06
GR3027566T3 (en) 1998-11-30
SI0721950T1 (en) 1998-10-31
KR100399541B1 (ko) 2003-12-31
PL312240A1 (en) 1996-07-22

Similar Documents

Publication Publication Date Title
CA1340362C (en) Thiadiazinones
CA2480384A1 (en) Phenanthridinones as parp inhibitors
JPH0717633B2 (ja) ヘテロアリールピペラジン抗精神病薬
CZ20004632A3 (cs) Derivát arylalkanoylpyridazinu, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
JPH03255063A (ja) セロトニン拮抗剤、それらの製造およびそれらを含有する薬学的組成物
JP2000511534A (ja) ベンゾオキサジノンドーパミンｄ４受容体アンタゴニスト
US5747489A (en) Arylalkyl-thiadiazinones
US5434149A (en) Thiadiazinones
SK280532B6 (sk) Derivát 3-alkoxykarbonyltiadiazinónu, spôsob jeho
JPH03106875A (ja) １―（３―ピリジルメチル）フタラジン誘導体
PL171273B1 (pl) Sposób wytwarzania nowych pochodnych tiadiazynonów PL
JPH04330078A (ja) 抗緑内障剤としての置換チエノ［２，３−ｂ］［１，４］チアジン−６−スルホンアミド類
US4443607A (en) 1(2H)-Isoquinolone compounds and acid addition salts thereof
US5137885A (en) Thiadiazinones
EP0579169B1 (en) Alkylenediamine derivatives
US4711889A (en) Schistosomicidal acridanone hydrazones
KR20020084274A (ko) 신규한 벤조술탐 옥사졸리디논 항균제
JPS6248679A (ja) カルボスチリル誘導体
US5276030A (en) Triazolyl thioamide derivates
JPH0631231B2 (ja) 抗精神病性４―［４―（３―ベンズイソチアゾリル）―１―ピペラジニルブチル架橋二環式イミド
CZ142693A3 (en) Thiadiazinone derivatives, process of their preparation and pharmaceutical preparations based thereon
JPS59167588A (ja) チアジアゾ−ル誘導体
JPS6254404B2 (es)